Abstract
Bioactive natural products are frequently glycosylated with saccharide chains of variable length. These sugars are important for the biological activity of the compounds and they contribute to the interaction with the biological target. The increasing knowledge of sugar biosynthesis pathways and the isolation of a large number of sugar gene clusters from antibiotic-producing actinomycetes are providing tools for combinatorial biosynthesis approaches that can generate potentially improved derivatives with altered sugars in their architecture. Novel derivatives of known bioactive natural products can be produced either in the producer organisms or in heterologous hosts by using different combinatorial biosynthesis strategies. In this article, recent advances in the field are discussed, illustrating the alternative approaches of gene inactivation, gene expression, combining gene inactivation and gene expression, co-expression of genes from different pathways or the use of sugar cassette plasmids to endow a host with the capability of synthesizing new sugars.
Keywords: Actinomycetes, Host Sugar Pathways, microorganisms, sugar biosynthesis genes, L-oleandrose, Elloramycin
Current Topics in Medicinal Chemistry
Title: Deoxysugars in Bioactive Natural Products: Development of Novel Derivatives by Altering the Sugar Pattern
Volume: 8 Issue: 8
Author(s): Carmen Mendez, Andriy Luzhetskyy, Andreas Bechthold and Jose A. Salas
Affiliation:
Keywords: Actinomycetes, Host Sugar Pathways, microorganisms, sugar biosynthesis genes, L-oleandrose, Elloramycin
Abstract: Bioactive natural products are frequently glycosylated with saccharide chains of variable length. These sugars are important for the biological activity of the compounds and they contribute to the interaction with the biological target. The increasing knowledge of sugar biosynthesis pathways and the isolation of a large number of sugar gene clusters from antibiotic-producing actinomycetes are providing tools for combinatorial biosynthesis approaches that can generate potentially improved derivatives with altered sugars in their architecture. Novel derivatives of known bioactive natural products can be produced either in the producer organisms or in heterologous hosts by using different combinatorial biosynthesis strategies. In this article, recent advances in the field are discussed, illustrating the alternative approaches of gene inactivation, gene expression, combining gene inactivation and gene expression, co-expression of genes from different pathways or the use of sugar cassette plasmids to endow a host with the capability of synthesizing new sugars.
Export Options
About this article
Cite this article as:
Mendez Carmen, Luzhetskyy Andriy, Bechthold Andreas and Salas A. Jose, Deoxysugars in Bioactive Natural Products: Development of Novel Derivatives by Altering the Sugar Pattern, Current Topics in Medicinal Chemistry 2008; 8 (8) . https://dx.doi.org/10.2174/156802608784221532
DOI https://dx.doi.org/10.2174/156802608784221532 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Development of Anti-Viral Agents Using Molecular Modeling and Virtual Screening Techniques
Infectious Disorders - Drug Targets The Role of Nanoparticles as Nanocarriers for the Controlled Release of some Potential Existing Antiviral Drugs for SARS-CoV-2 Management: A Review
Coronaviruses FDG-PET Scan in Sarcoidosis: Clinical and Imaging Indications
Current Medical Imaging Building Nanoscale Architectures by Directed Synthesis and Self-Assembly
Current Nanoscience Crosstalk among Jasmonate, Salicylate and Ethylene Signaling Pathways in Plant Disease and Immune Responses
Current Protein & Peptide Science Drug Discovery of Acetophenone Derivatives as BRD4 Inhibitors
Letters in Drug Design & Discovery The Appearance of Middle Meningeal Artery Fistulae After Willis Covered Stent for Traumatic Carotid-cavernous Fistulae: Two Case Reports
Current Medical Imaging Computer-Aided Drug Design Applied to Secondary Metabolites as Anticancer Agents
Current Topics in Medicinal Chemistry Nanocrystalline ZnO: A Competent and Reusable Catalyst for the Preparation of Pharmacology Relevant Heterocycles in the Aqueous Medium
Current Green Chemistry Targeting Natural Products for the Treatment of COVID-19 – An Updated Review
Current Pharmaceutical Design Derivatives of Cephalothin that Inhibit Ampicillin Resistant Escherichia Coli
Medicinal Chemistry Post-Translational Modification of Orphan Nuclear Receptors TR2 and TR4 – Ligand Independent Activities
Current Proteomics New Quinolinyl–1,3,4–Oxadiazoles: Synthesis, In Vitro Antibacterial, Antifungal and Antituberculosis Studies
Medicinal Chemistry Coronavirus Disease 2019: Virology and Drug Targets
Infectious Disorders - Drug Targets Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes
Current Genomics QSAR and Pharmacophore Analysis of a Series of Piperidinyl Urea Derivatives as hERG Blockers and H3 Antagonists
Current Drug Discovery Technologies Potent Non-Peptide Thrombin Receptor Antagonists
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Maternal Sepsis: Current Approaches to Recognition and Clinical Management
Current Women`s Health Reviews Paclitaxel Formulations: Challenges and Novel Delivery Options
Current Drug Delivery Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands
Current Neuropharmacology